BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1806363)

  • 1. Stimulation of GM3 ganglioside sialidase activity by an activator protein in patients with mucolipidosis IV and controls.
    Ben-Yoseph Y; Mitchell DA; Yager RM; Pretzlaff RK
    Enzyme; 1991; 45(1-2):23-9. PubMed ID: 1806363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some properties.
    Lieser M; Harms E; Kern H; Bach G; Cantz M
    Biochem J; 1989 May; 260(1):69-74. PubMed ID: 2775195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane.
    Miyagi T; Tsuiki S
    FEBS Lett; 1986 Oct; 206(2):223-8. PubMed ID: 3758350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sialic acid residue of exogenous GM1 ganglioside is recycled for biosynthesis of sialoglycoconjugates in rat liver.
    Ghidoni R; Trinchera M; Sonnino S; Chigorno V; Tettamanti G
    Biochem J; 1987 Oct; 247(1):157-64. PubMed ID: 3689344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytically defective ganglioside neuraminidase in mucolipidosis IV.
    Ben-Yoseph Y; Momoi T; Hahn LC; Nadler HL
    Clin Genet; 1982 Jun; 21(6):374-81. PubMed ID: 6813002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of ganglioside-amides in cultured human fibroblasts.
    Klein D; Pohlentz G; Hinrichs U; Sandhoff K
    Biol Chem Hoppe Seyler; 1987 Nov; 368(11):1495-503. PubMed ID: 3124867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal and plasma membrane ganglioside GM3 sialidases of cultured human fibroblasts. Differentiation by detergents and inhibitors.
    Schneider-Jakob HR; Cantz M
    Biol Chem Hoppe Seyler; 1991 Jun; 372(6):443-50. PubMed ID: 1910582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secretary sialidase activity and GM3 ganglioside].
    Usuki S; Sweeley CC
    Hum Cell; 1989 Mar; 2(1):15-21. PubMed ID: 2519199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2.
    Li SC; Serizawa S; Li YT; Nakamura K; Handa S
    J Biol Chem; 1984 May; 259(9):5409-10. PubMed ID: 6232275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A; Holding J; Carey WF
    Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the interaction of Clostridium perfringens sialidase with sialic acid linked to the internal galactose in monosialogangliotetraosyl ceramide.
    Corfield AP; Schauer R; Dorland L; Vliegenthart JF; Wiegandt H
    J Biochem; 1985 Feb; 97(2):449-61. PubMed ID: 2861198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialidase activities of cultured human fibroblasts and the metabolism of GM3 ganglioside.
    Usuki S; Lyu SC; Sweeley CC
    J Biol Chem; 1988 May; 263(14):6847-53. PubMed ID: 3129431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective ganglioside desialylation in the plasma membrane of human neuroblastoma cells.
    Kopitz J; von Reitzenstein C; Sinz K; Cantz M
    Glycobiology; 1996 Apr; 6(3):367-76. PubMed ID: 8724144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
    Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
    J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucolipidosis I: studies of sialidase activity and a prenatal diagnosis.
    Mueller OT; Wenger DA
    Clin Chim Acta; 1981 Feb; 109(3):313-24. PubMed ID: 7226521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An activator protein of oligosaccharide sialidase.
    Chabás A; Guardiola A; Burguera JM
    Biochem Int; 1987 Aug; 15(2):449-57. PubMed ID: 3124850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope.
    Delorme C; Brüssow H; Sidoti J; Roche N; Karlsson KA; Neeser JR; Teneberg S
    J Virol; 2001 Mar; 75(5):2276-87. PubMed ID: 11160731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucolipidosis type IV: ganglioside sialidase deficiency.
    Bach G; Zeigler M; Schaap T; Kohn G
    Biochem Biophys Res Commun; 1979 Oct; 90(4):1341-7. PubMed ID: 518603
    [No Abstract]   [Full Text] [Related]  

  • 20. Substrate specificity and inhibitor studies of a membrane-bound ganglioside sialidase isolated from human brain tissue.
    Oehler C; Kopitz J; Cantz M
    Biol Chem; 2002 Nov; 383(11):1735-42. PubMed ID: 12530538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.